Product NDC: | 0093-6723 |
Proprietary Name: | Ipratropium Bromide and Albuterol Sulfate |
Non Proprietary Name: | Ipratropium Bromide and Albuterol Sulfate |
Active Ingredient(s): | 2.5; .5 mg/3mL; mg/3mL & nbsp; Ipratropium Bromide and Albuterol Sulfate |
Administration Route(s): | RESPIRATORY (INHALATION) |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-6723 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076724 |
Marketing Category: | ANDA |
Start Marketing Date: | 20080102 |
Package NDC: | 0093-6723-73 |
Package Description: | 6 POUCH in 1 CARTON (0093-6723-73) > 5 VIAL, PLASTIC in 1 POUCH (0093-6723-45) > 3 mL in 1 VIAL, PLASTIC |
NDC Code | 0093-6723-73 |
Proprietary Name | Ipratropium Bromide and Albuterol Sulfate |
Package Description | 6 POUCH in 1 CARTON (0093-6723-73) > 5 VIAL, PLASTIC in 1 POUCH (0093-6723-45) > 3 mL in 1 VIAL, PLASTIC |
Product NDC | 0093-6723 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ipratropium Bromide and Albuterol Sulfate |
Dosage Form Name | SOLUTION |
Route Name | RESPIRATORY (INHALATION) |
Start Marketing Date | 20080102 |
Marketing Category Name | ANDA |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | ALBUTEROL SULFATE; IPRATROPIUM BROMIDE |
Strength Number | 2.5; .5 |
Strength Unit | mg/3mL; mg/3mL |
Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |